CLINICAL_TRIALS
trial_result
· 2016-08-15
Clinical Trial Update: Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction [Phase 4]
Summary
Phase 4 trial update on the impact of eplerenone on cardiovascular outcomes after myocardial infarction.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED | Results posted: 2016-08-15